Hemodynamic Effects of Surgical Position in Prone vs. Supine Percutaneous Nephrolithotomy
NCT ID: NCT07138872
Last Updated: 2025-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
84 participants
INTERVENTIONAL
2025-06-01
2025-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hemodynamic Changes Due to Prone Position
NCT04491331
The Effect of Different Bed-Head Angles on the Haemodynamic Parameters of Intensive Care Patients Lying in the Supine Position
NCT06020768
Effect of Prone Position on Liver Blood Flow and Function
NCT01781260
The Effects of Prolonged Head-Down Tilt Lithotomy Position on Lower Limb Haemodynamics
NCT06036641
Changes of Intra Abdominal Pressure During Surgeries in Prone Position as a Marker of Renal Damage
NCT05626868
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Previous literature suggests that the prone position may increase intrathoracic pressure and impair venous return, potentially compromising hemodynamic stability, while the supine position may provide a more stable cardiovascular profile. However, existing data are limited, and results remain inconclusive, particularly in direct comparative studies.
This prospective, randomized controlled clinical trial aims to compare the effects of prone and supine positions during PNL on patients' intraoperative and postoperative hemodynamic parameters. The study will enroll 84 patients aged 18-80 years with American Society of Anesthesiologists (ASA) physical status I-III undergoing elective PNL. Patients will be randomly assigned to either the prone (n=42) or supine (n=42) position.
Inclusion criteria include patients with renal calculi suitable for PNL and meeting the study's eligibility requirements. Exclusion criteria include pregnancy, uncontrolled coagulopathy, previous renal surgery, severe cardiac, pulmonary, or neurological disease, preoperative urinary tract infection, surgery duration outside 60-120 minutes, and multiple access tracts.
Preoperative evaluation will include demographic data, stone characteristics, and relevant laboratory and imaging findings. Intraoperative data will include systolic and diastolic blood pressure, heart rate, arterial blood gas analysis, operative time, anesthesia duration, access details, irrigation volume, and any transfusion or complications. Postoperative parameters will include nephrostomy duration, length of hospital stay, and presence of residual stones as assessed by postoperative CT scan.
Surgical techniques will be standardized for both positions. Prone PNL will involve initial lithotomy positioning for ureteral catheter placement followed by prone positioning for renal access under fluoroscopic guidance. Supine PNL will be performed in the Galdakao-modified Valdivia position with similar access and fragmentation protocols.
The primary outcome is the difference in intraoperative and postoperative hemodynamic stability between positions. Secondary outcomes include complication rates, residual stone rates, and hospital stay duration.
This study aims to provide high-quality evidence to guide surgeons and anesthesiologists in selecting the optimal patient position for PNL, particularly in individuals with higher hemodynamic risk.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prone Position
Patients in this group will undergo percutaneous nephrolithotomy (PNL) in the prone position. The procedure begins with ureteral catheter placement in lithotomy position, followed by prone positioning for renal access under C-arm fluoroscopic guidance. Stone fragmentation will be performed using pneumatic or ultrasonic lithotripters, and nephrostomy placement will be completed according to standard protocol.
Prone Position Percutaneous Nephrolithotomy
Patients in this arm will undergo percutaneous nephrolithotomy (PNL) in the prone position. The procedure begins with ureteral catheter placement in lithotomy position, followed by prone positioning for renal access under C-arm fluoroscopic guidance. Stone fragmentation will be performed using pneumatic or ultrasonic lithotripters, and nephrostomy placement will be completed according to standard protocol.
Supine Position
Patients in this group will undergo percutaneous nephrolithotomy (PNL) in the Galdakao-modified Valdivia supine position. Following general anesthesia, the ipsilateral side will be elevated 20-30°, with the ipsilateral leg extended and the contralateral leg abducted. Ureteral catheter placement will be followed by renal access under C-arm fluoroscopy. Stone fragmentation and removal will be performed using the same standardized lithotripsy and irrigation protocols as in the prone group.
Supine Position Percutaneous Nephrolithotomy (Galdakao-modified Valdivia)
Patients in this arm will undergo percutaneous nephrolithotomy (PNL) in the Galdakao-modified Valdivia supine position. Following general anesthesia, the ipsilateral side will be elevated 20-30°, with the ipsilateral leg extended and the contralateral leg abducted. Ureteral catheter placement will be followed by renal access under C-arm fluoroscopy. Stone fragmentation and removal will be performed using the same standardized lithotripsy and irrigation protocols as in the prone group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prone Position Percutaneous Nephrolithotomy
Patients in this arm will undergo percutaneous nephrolithotomy (PNL) in the prone position. The procedure begins with ureteral catheter placement in lithotomy position, followed by prone positioning for renal access under C-arm fluoroscopic guidance. Stone fragmentation will be performed using pneumatic or ultrasonic lithotripters, and nephrostomy placement will be completed according to standard protocol.
Supine Position Percutaneous Nephrolithotomy (Galdakao-modified Valdivia)
Patients in this arm will undergo percutaneous nephrolithotomy (PNL) in the Galdakao-modified Valdivia supine position. Following general anesthesia, the ipsilateral side will be elevated 20-30°, with the ipsilateral leg extended and the contralateral leg abducted. Ureteral catheter placement will be followed by renal access under C-arm fluoroscopy. Stone fragmentation and removal will be performed using the same standardized lithotripsy and irrigation protocols as in the prone group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of renal calculi indicated for PNL
Exclusion Criteria
* Uncontrolled coagulopathy
* Previous renal surgery
* Severe cardiac, pulmonary, or neurological disease
* Preoperative urinary tract infection (non-sterile urine culture)
* Surgery duration \<60 minutes or \>120 minutes
* Preoperative blood transfusion
* Multiple access tracts
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gaziosmanpasa Research and Education Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arif Burak Keçebaş
UROLOGY DOCTOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Burak Arslan, CLINICAL PROFESSOR OF UROLOGY
Role: STUDY_DIRECTOR
Gaziosmanpaşa Training and Research Hospital, Urology Department, Istanbul, Türkiye
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gaziosmanpaşa Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AIBU-SBF-ABK-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.